Deep Track Capital, LP 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:34 am Sale |
2022-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Deep Track Capital, LP | 0 0.000% |
-3,646,690 (Position Closed) |
Filing |
| 2022-06-17 4:04 pm Purchase |
2022-06-10 | 13G | Global Blood Therapeutics, Inc. GBT |
Deep Track Capital, LP | 3,646,690 5.600% |
3,646,690 (New Position) |
Filing |